A chronic reference value for 1,3-butadiene based on an updated noncancer toxicity assessment

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 13, Issue 6, 2010, Pages 460-475

  Grant, Roberta L ^a   Haney, Joseph ^a   Curry, Angela L ^a   Honeycutt, Michael ^a  

^a Texas Commission on Environmental Quality   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; HEMOGLOBIN;

AIR MONITORING; AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL PROTECTION; FEMALE; HUMAN; METABOLITE; MOUSE; NONHUMAN; OVARY ATROPHY; OVARY DISEASE; RAT; REFERENCE VALUE; RISK FACTOR; TOXICITY; TOXICOKINETICS;

ANIMALS; ATROPHY; BUTADIENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MACACA FASCICULARIS; MALE; MICE; OVARY; PREGNANCY; RATS; REFERENCE VALUES;

ANIMALIA; MUS; RATTUS;

EID: 77955638349     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937404.2010.499735     Document Type: Article

References (65)

1. Albertini, R. J. 2007. Polymorphisms in metabolic genes: Relevance for human susceptibility to butadiene. Responses to comments received on the 1,3-butadiene Development Support Document original dated August 2007 and revised dated June 2008. Texas Commission on Environmental Quality. Available at http://www.tceq.state.tx.us/implementation/tox/dsd/final.html
2. Albertini, R. J., Sram, R. J., Vacek, P. M., Lynch, J., Nicklas, J. A., van Sittert, N. J., Boogaard, P. J., Henderson, R. F., Swenberg, J. A., Tates, A. D., Ward, J. B., Jr., Wright, M., Ammenheuser, M. M., Binkova, B., Blackwell, W., de Zwart, F. A., Krako, D., Krone, J., Megens, H., Musilova, P., Rajska, G., Ranasinghe, A., Rosenblatt, J. I., Rossner, P., Rubes, J., Sullivan, L., Upton, P., and Zwinderman
3. Albertini, R. J., Sram, R. J., Vacek, P. M., Lynch, J., Nicklas, J. A., van Sittert, N. J., Boogaard, P. J., Henderson, R. F., Swenberg, J. A., Tates, A. D., Ward, J. B., Jr., Wright, M., Ammenheuser, M. M., Binkova, B., Blackwell, W., de Zwart, F. A., Krako, D., Krone, J., Megens, H., Musilova, P., Rajska, G., Ranasinghe, A., Rosenblatt, J. I., Rossner, P., Rubes, J., Sullivan, L., Upton, P., and Zwinderman, A. H. 2003. Biomarkers in Czech workers exposed to 1,3-butadiene: A transitional epidemiologic study. Res. Rep. Health Effects Inst. pp. 1-141; discussion 116: 143-162.
4. Albertini, R. J., Sram, R. J., Vacek, P. M., Lynch, J., Rossner, P., Nicklas, J. A., McDonald, J. D., Boysen, G., Georgieva, N., and Swenberg, J. A. 2007. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: Female-male comparisons. Chem. Biol. Interact. 166:63-77.
5. Albertini, R. J., Sram, R. J., Vacek, P. M., Lynch, J., Wright, M., Nicklas, J. A., Boogaard, P. J., Henderson, R. F., Swenberg, J. A., Tates, A. D., and Ward, J. B., Jr. 2001. Biomarkers for assessing occupational exposures to 1,3-butadiene. Chem. Biol. Interact. 135-136:429-453.
6. American Chemistry Council. 2003. An inhalation reproduction/ developmental toxicity screening study of 1,3-butadiene in rats. OLF-68.0-BD-HPV-WIL. Ashland, OH: WIL Research Laboratories.
7. Begemann, P., Sram, R. J., and Neumann, H. G. 2001. Hemoglobin adducts of epoxybutene in workers occupationally exposed to 1,3-butadiene. Arch. Toxicol. 74:680-687.
8. Brochot, C., Smith, T. J., and Bois, F. Y. 2007. Development of a physiologically based tox-icokinetic model for butadiene and four major metabolites in humans: global sensitivity analysis for experimental design issues. Chem. Biol. Interact. 167, 168-183.
9. Csanady, G. A., Guengerich, F. P., and Bond, J. A. 1992. Comparison of the biotransfor-mation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 13:1143-1153.
10. Dahl, A. R., Bechtold, W. E., Bond, J. A., Henderson, R. F., Mauderly, J. L., Muggenburg, B. A., Sun, J. D., and Birnbaum, L. S. 1990. Species differences in the metabolism and disposition of inhaled 1,3-butadiene and isoprene. Environ. Health Perspect. 86:65-69.
11. Dahl, A. R., and Henderson, R. F. 2000. Comparative metabolism of low concentrations of butadiene and its monoepoxide in human and monkey hepatic microsomes. Inhal. Toxicol. 12:439-451.
12. Dahl, A. R., Sun, J. D., Birnbaum, L. S., Bond, J. A., Griffith, W. C., Jr., Mauderly, J. L., Muggenburg, B. A., Sabourin, P. J., and Henderson, R. F. 1991. Toxicokinetics of inhaled 1,3-butadiene in monkeys: Comparison to toxicokinetics in rats and mice. Toxicol. Appl. Pharmacol. 110:9-19.
13. Doerr, J. K., Hollis, E. A., and Sipes, I. G. 1996. Species difference in the ovarian tox-icity of 1,3-butadiene epoxides in B6C3F1 mice and Sprague-Dawley rats. Toxicology 113:128-136.
14. Doerr, J. K., Hooser, S. B., Smith, B. J., and Sipes, I. G. 1995. Ovarian toxicity of 4-vinylcyclohexene and related olefins in B6C3F1 mice: Role of diepoxides. Chem. Res. Toxicol. 8:963-969.
15. Duescher, R. J., and Elfarra, A. A. 1994. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: Evidence for major roles by cytochromes P450 2A6 and 2E1. Arch. Biochem. Biophys. 311:342-349.
16. Fennell, T. R. Sumner, S. C. J., Snyder, R. W., Burgess, J., Spicer, R., Bridson, W. E., and Friedman, M. A. 2005. Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol. Sci. 85:447-459.
17. Filser, J. G., Hutzler, C., Meischner, V., Veereshwarayya, V., and Csanady, G. A. 2007. Metabolism of 1,3-butadiene to tox-icologically relevant metabolites in single-exposed mice and rats. Chem. Biol. Interact. 166:93-103.
18. Fred, C., Tornqvist, M., and Granath, F. 2008. Evaluation of cancer tests of 1,3-butadiene using internal dose, genotoxic potency, and a multiplicative risk model. Cancer Res. 68:8014-8021.
19. Fustinoni, S., Soleo, L., Warholm, M., Begemann, P., Rannug, A., Neumann, H. G., Swenberg, J. A., Vimercati, L., and Colombi, A. 2002. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiol. Biomarkers Prev. 11:1082-1090.
20. Georgieva, N. I., Boysen, G., Upton, P., Sram, R., Albertini, R., and Swenberg, J. A. 2007. Analysis of 1,2;3,4-diepoxybutane specific protein adduct in occupationally exposed workers. Toxicologist 428:89.
21. Georgieva, N. I., Boysen, G., Upton, P., Vacek, P., Shram, R., Albertini, R., and Swenberg, J. 2008. Analysis of 1,2;3,4-diepoxybutane specific protein adduct in occupationally exposed workers, Part 2. Toxicologist 429:356-357.
22. Grant, R. L., Haney, J., Curry, A. L., and Honeycutt, M. 2009. Development of a unit risk factor for 1,3-butadiene based on an updated carcinogenic toxicity assessment. Risk Anal. 29:1726-1742.
23. Grant, R. L., Leopold, V., McCant, D., and Honeycutt, M. 2007. Spatial and temporal trend evaluation of ambient concentrations of 1,3-butadiene and chloroprene in Texas. Chem. Biol. Interact. 166:44-51.
24. Hackett, P. L., Sikov, M. R., Mast, T. J., Brown, M. G., Buschbom, R. L., Clark, M. L., Decker, J. R., Evanoff, J. J., Rommereim, R. L., Rowe, S. E., and Westerberg, R.B. 1987a. Inhalation developmental toxicology studies of 1,3-butadiene in the rat (Final report). PNL Report No. PNL-6414 UC-48; NIH Report No. NIH-401-ES-40131. Richland, WA: Pacific Northwest Laboratory.
25. Hackett, P. L., Sikov, M. R., Mast, T. J., Brown, M. G., Buschbom, R. L., Clark, M. L., Decker, J. R., Evanoff, J. J., Rommereim, R. L., Rowe, S. E., and Westerberg, R. B. 1987b. Inhalation developmental toxicology studies: Teratology study of 1,3-butadiene in mice (Final report). PNL Report No. PNL-6412 UC-48; NIH Report No. NIH-401-ES-40131. Richland, WA: Pacific Northwest Laboratory.
26. Hayes, R. B., Xi, L., Bechtold, W. E., Rothman, N., Yao, M., Henderson, R., Zhang, L., Smith, M. T., Zhang, D., Wiemels, J., Dosemeci, M., Yin, S., and O'Neill, J. P. 1996. hprt Mutation frequency among workers exposed to 1,3-butadiene in China. Toxicology 113:100-105.
27. Hayes, R. B., Zhang, L., Swenberg, J. A., Yin, S. N., Xi, L., Wiencke, J., Bechtold, W. E., Yao, M., Rothman, N., Haas, R., O'Neill, J. P., Wiemels, J., Dosemeci, M., Li, G., and Smith, M. T. 2001. Markers for carcino-genicity among butadiene-polymer workers in China. Chem. Biol. Interact. 135-136: 455-464.
28. Hayes, R. B., Zhang, L., Yin, S., Swenberg, J. A., Xi, L., Wiencke, J., Bechtold, W. E., Yao, M., Rothman, N., Haas, R., O'Neill, J. P., Zhang, D., Wiemels, J., Dosemeci, M., Li, G., and Smith, M. T. 2000. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis 21:55-62.
29. Hazleton Laboratories Europe. 1981. The toxicity and carcinogenicity of butadiene gas administered to rats by inhalation for approximately 24 months. The International Institute of Synthetic Rubber Producers. New York: Hazleton Laboratories Europe, Ltd.
30. Henderson, R. F. 2001. Species differences in the metabolism of olefins: Implications for risk assessment. Chem. Biol. Interact. 135-136:53-64.
31. Henderson, R. F., Thornton-Manning, J. R., Bechtold, W. E., and Dahl, A. R. 1996. Metabolism of 1,3-butadiene: Species differences. Toxicology 113:17-22.
32. Himmelstein, M. W., Acquavella, J. F., Recio, L., Medinsky, M. A., and Bond, J. A. 1997. Toxicology and epidemiology of 1,3-butadiene. Crit. Rev. Toxicol. 27:1-108.
33. International Institute of Synthetic Rubber Producers. 1982. 1,3-Butadiene: Inhalation teratogenicity in the rat (Final report with cover letter dated 08/11/82). Report no. 2788-522/3; submission 8EHQ-0382-0441. Harrowgate, England: Hazleton Laboratories Europe, Ltd.
34. International Programme on Chemical Safety. 2005. Chemical-specific adjustment factors for interspecies differences and human variability: Guidance document for use of data in dose/concentration-response assessment. International Programme on Chemical Safety, World Health Organization, available at http://whqlibdoc.who.int/publications/2005/9241546786-eng.pdf
35. Miller, L. M. 1978. Investigation of selected potential environmental contaminants: Butadiene and its oligomers. EPA-560/2-78-1008 Washington, DC: U.S. Environmental Protection Agency.
36. National Research Council. 1983. Risk assessment in the federal government. Washington, DC: National Research Council, National Academy Press.
37. National Research Council. 1994. Science and judgment in risk assessment. Washington, DC: National Research Council, National Academy Press.
38. National Research Council. 2001. Standing operating procedures for developing acute exposure guideline levels for hazardous chemicals. Washington, DC: National Research Council, National Academy Press.
39. National Toxicology Program. 1993. NTP technical report on the toxicology and car-cinogenesis studies of 1,3-butadiene (CAS No. 106-99-0) in B6C3F1 mice (inhala-tional studies). Research Triangle Park, NC: National Toxicology Program, U.S. Department of Health and Human Services Public Health Service, National Institute of Health. NTP TR 434, NIH Publication No. 93-3165.
40. Office of Environmental Health Hazard Assessment. 1999. Part 1, The determination of acute reference exposure levels for airborne toxicants. Sacramento: Office of Environmental Health Hazard Assessment, California Environmental Protection Agency.
41. Office of Environmental Health Hazard Assessment. 2000. Part III, Technical support document for the determination of noncancer chronic reference exposure levels. Sacramento: Office of Environmental Health Hazard Assessment, California Environmental Protection Agency.
42. Owen, P. E., and Glaister, J. R. 1990. Inhalation toxicity and carcinogenicity of 1,3-butadiene in Sprague-Dawley rats. Environ. Health Perspect. 86:19-25.
43. Owen, P. E., Glaister, J. R., Gaunt, I. F., and Pullinger, D. H. 1987. Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/ carcinogenicity study in rats. Am. Ind. Hyg. Assoc. J. 48:407-413.
44. Sabourin, P. J., Burka, L. T., Bechtold, W. E., Dahl, A. R., Hoover, M. D., Chang, I. Y., and Henderson, R. F. 1992. Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4-(N-acetylcysteinyl) butane, a novel metabolite of butadiene. Carcinogenesis 13:1633-1638.
45. Seaton, M. J., Follansbee, M. H., and Bond, J. A. 1995. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 16:2287-2293.
46. Slikker, W., Jr., Andersen, M. E., Bogdanffy, M. S., Bus, J. S., Cohen, S. D., Conolly, R. B., David, R. M., Doerrer, N. G., Dorman, D. C., Gaylor, D. W., Hattis, D., Rogers, J. M., Setzer, R. W., Swenberg, J. A., and Wallace, K. 2004a. Dose-dependent transitions in mechanisms of toxicity: Case studies. Toxicol. Appl. Pharmacol. 201:226-294.
47. Slikker, W., Jr., Andersen, M. E., Bogdanffy, M. S., Bus, J. S., Cohen, S. D., Conolly, R. B., David, R. M., Doerrer, N. G., Dorman, D. C., Gaylor, D. W., Hattis, D., Rogers, J. M., Woodrow Setzer, R., Swenberg, J. A., and Wallace, K. 2004b. Dose-dependent transitions in mechanisms of toxicity. Toxicol. Appl. Pharmacol. 201:203-225.
48. Smith, T. J., Lin, Y. S., Mezzetti, M., Bois, F. Y., Kelsey, K., and Ibrahim, J. 2001. Genetic and dietary factors affecting human metabolism of 1,3-butadiene. Chem. Biol. Interact. 135-136:407-428.
49. Swenberg, J. A., Boysen, G., Georgieva, N., Bird, M. G., and Lewis, R. J. 2007. Future directions in butadiene risk assessment and the role of cross-species internal dosimetry. Chem. Biol. Interact. 166:78-83.
50. Texas Commission on Environmental Quality. 2006. Guidelines to develop effects screening levels, reference values, and unit risk factors, RG-442. Texas Commission on Environmental Quality, available at http://www.tceq.state.tx.us/ comm-exec/forms-pubs/pubs/rg/rg-442.html
51. Texas Commission on Environmental Quality. 2008a. Development support document 1,3-butadiene CAS registry number: 106-99-100 Texas Commission on Environmental Quality, Toxicology Section, Chief Engineer's Office, available at http://www.tceq.state.tx.us/implementation/tox/dsd/final.html
52. Texas Commission on Environmental Quality. 2008b. Responses to comments received on the 1,3-butadiene development support document original dated August 2007 and revised dated June 2008. Texas Commission on Environmental Quality, available at http://www.tceq.state.tx.us/implementation/tox/dsd/final.html
53. Toxicology Excellence for Risk Assessment. 2007. Peer review of the Development Support Document (DSD) for 1,3-Butadiene prepared by the Texas Commission on Environmental Quality (TCEQ), Toxicology Excellence for Risk Assessment, http://www.tera.org/peer/TCEQ-1,3butadiene.html
54. Thornton-Manning, J. R., Dahl, A. R., Bechtold, W. E., Griffith, W. C., Jr., and Henderson, R. F. 1995. Disposition of butadiene monoe-poxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 16:1723-1731.
55. Tsai, S. P., Ahmed, F. S., Ransdell, J. D., Wendt, J. K., and Donnelly, R. P. 2005. A hematology surveillance study of petrochemical workers exposed to 1,3 butadiene. J. Occup. Environ. Hyg. 2:508-515.
56. U.S. Environmental Protection Agency. 1994. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. EPA/600/8-90/066F. Washington, DC: U.S. Environmental Protection Agency, Office of Research and Development, Washington, DC.
57. U.S. Environmental Protection Agency. 1998. Review of the Office of Research and Development's draft health risk assessment of 1,3-butadiene prepared by the environmental health committee of the Science Advisory Board SAB. EPA-SAB-EHC-99-1003 Washington, DC: U.S. Environmental Protection Agency.
58. U.S. Environmental Protection Agency. 2000. Benchmark dose technical guidance document. EPA/630/R-00/001. Washington, DC: U.S. Environmental Protection Agency, Risk Assessment Forum.
59. U.S. Environmental Protection Agency. 2002a. Health assessment of 1,3-butadiene. EPA/600/P-98/001F. Washington, DC: U.S. Environmental Protection Agency, National Center for Environmental Assessment, Office of Research and Development.
60. U.S. Environmental Protection Agency. 2002b. A review of the reference dose and reference concentration processes. EPA/630/P-02/002F. Washington, DC: U.S. Environmental Protection Agency, Risk Assessment Forum.
61. U.S. Environmental Protection Agency. 2005. Approaches for the application of physiologically based pharmacokinetic (PBPK) models and supporting data in risk assessment. EPA/600/R-05/043A. Washington, DC: U.S. Environmental Protection Agency, Office of Research and Development.
62. U.S. Environmental Protection Agency. 2008. Toxicological review of carbon tetrachloride. EPA/635/R-08/005A. Washington, DC: U.S. Environmental Protection Agency.
63. Weincke, J. K., and Kelsey, K. T. 1993. Susceptibility to induction of chromosomal damage by metabolites of 1,3-butadiene and its relationship to 'spontaneous' sister chromatid exchange frequencies in human lymphocytes. In Butadiene and styrene: Assessment of health hazards, eds. M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki, pp. 265-273. Lyon, France: IARC.
64. Zhao, C., Vodicka, P., Sram, R. J., and Hemminki, K. 2000. Human DNA adducts of 1,3-butadiene, an important environmental carcinogen. Carcinogenesis 21:107-111.
65. Zhao, C., Vodicka, P., Sram, R. J., and Hemminki, K. 2001. DNA adducts of 1,3-butadiene in humans: Relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points. Environ. Mol. Mutagen. 37:226-230.